Ignite Creation Date:
2025-12-25 @ 4:25 AM
Ignite Modification Date:
2026-05-05 @ 4:20 AM
Study NCT ID:
NCT04281420
Status:
TERMINATED
Last Update Posted:
2024-04-30
First Post:
2020-02-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Sponsor:
Antengene Therapeutics Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Solid Tumor, Non-Hodgkin's Lymphoma | View |
Keywords: